Skip to main content
Erschienen in: Pediatric Cardiology 2/2012

01.02.2012 | Original Article

Usefulness of Doppler Derived End Diastolic Flow Gradient Across the Patent Ductus Arteriosus in Selecting Coils for Ductal Occlusion

verfasst von: Amit Kumar Chaurasia, S. Harikrishnan, S. Bijulal, K. M. Krishnamoorthy, S. Sivasankaran, J. A. Tharakan

Erschienen in: Pediatric Cardiology | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Transcatheter closure of patent ductus arteriosus (PDA) with coils is accepted as an alternative to surgical ligation. We evaluated whether flow gradient across PDA, obtained by Doppler echocardiography, can aid in selecting coils for percutaneous ductal occlusion. 79 consecutive patients with PDA, who underwent successful percutaneous coil occlusion were retrospectively reviewed. Patients with other structural heart disease and pulmonary hypertension with right-to-left shunt were excluded. Echocardiogram and cardiac catheterization were done in all patients. Gianturco (Occluding Spring Emboli; Cook, Bloomington, IN) non-detachable coils of 0.038 and 0.052-inch core sizes were used for ductal occlusion. Trough diastolic gradient was correlated with the size and the number of coils used. Mean age was 8.6 years (range 1.3 to 27 years); 24 males and 55 females; PDA diameter ranged from 1.3 to 4.5 mm. Number of coils used varied from 1 to 4. Echocardiography measured PDA size was 2.5 ± 0.6 mm and significantly differed from angiographically measured size 2.9 ± 0.6 mm (P = 0.05). End diastolic gradient below 38 mmHg predicted use of multiple coils or coils with larger surface area. End diastolic gradient correlated inversely with total surface area of the coils, which indirectly predicted size and number of coils. Thus, the prediction of the size and the number of coils for PDA occlusion can be assisted by the trough diastolic gradients of PDA.
Literatur
1.
Zurück zum Zitat Allen HD, Beekman RH III, Garson A Jr et al (1998) AHA scientific statement: pediatric therapeutic cardiac catheterization: a statement for healthcare professionals from the council on cardiovascular disease in the young. American Heart Association. Circulation 97:609–625PubMed Allen HD, Beekman RH III, Garson A Jr et al (1998) AHA scientific statement: pediatric therapeutic cardiac catheterization: a statement for healthcare professionals from the council on cardiovascular disease in the young. American Heart Association. Circulation 97:609–625PubMed
2.
Zurück zum Zitat Galal MO (2003) Advantages and disadvantages of coils for transcatheter closure of patent ductus arteriosus. J Interv Cardiol 16:157–163PubMedCrossRef Galal MO (2003) Advantages and disadvantages of coils for transcatheter closure of patent ductus arteriosus. J Interv Cardiol 16:157–163PubMedCrossRef
3.
Zurück zum Zitat Krichenko A, Lee B, Burrows P, Moes CAF, McLaughlin P, Freedom R (1989) Angiographic classification of the isolated, persistently PDA and implications for percutaneous catheter occlusion. Am J Cardiol 63:877–880PubMedCrossRef Krichenko A, Lee B, Burrows P, Moes CAF, McLaughlin P, Freedom R (1989) Angiographic classification of the isolated, persistently PDA and implications for percutaneous catheter occlusion. Am J Cardiol 63:877–880PubMedCrossRef
4.
Zurück zum Zitat Kumar RK, Anil SR, Kannan BR, Philip A, Sivakumar K (2004) Bioptome-assisted coil occlusion of moderate-large patent ductus arteriosus in infants and small children. Catheter Cardiovasc Interv 62:266–271PubMedCrossRef Kumar RK, Anil SR, Kannan BR, Philip A, Sivakumar K (2004) Bioptome-assisted coil occlusion of moderate-large patent ductus arteriosus in infants and small children. Catheter Cardiovasc Interv 62:266–271PubMedCrossRef
5.
Zurück zum Zitat Liang CD, Ko SF, Huang SC (2003) Echocardiographic guidance for transcatheter coil occlusion of patent ductus arteriosus in the catheterization laboratory. J Am Soc Echocardiogr 16:476–479PubMedCrossRef Liang CD, Ko SF, Huang SC (2003) Echocardiographic guidance for transcatheter coil occlusion of patent ductus arteriosus in the catheterization laboratory. J Am Soc Echocardiogr 16:476–479PubMedCrossRef
6.
Zurück zum Zitat Lu CZ, Hu YY, Xu QL (1991) Determination of pressure gradient across patent ductus arteriosus with simultaneous continuous wave Doppler and catheterization methods and noninvasive estimation of pulmonary artery pressure. Zhonghua Nei Ke Za Zhi 30:550–553 (Abstract in English)PubMed Lu CZ, Hu YY, Xu QL (1991) Determination of pressure gradient across patent ductus arteriosus with simultaneous continuous wave Doppler and catheterization methods and noninvasive estimation of pulmonary artery pressure. Zhonghua Nei Ke Za Zhi 30:550–553 (Abstract in English)PubMed
7.
Zurück zum Zitat Musewe NN, Smallhorn JF, Benson LN, Burrows PE, Freedom RM (1987) Validation of Doppler-derived pulmonary arterial pressure in patients with ductus arteriosus under different hemodynamic states. Circulation 76:1081–1091PubMedCrossRef Musewe NN, Smallhorn JF, Benson LN, Burrows PE, Freedom RM (1987) Validation of Doppler-derived pulmonary arterial pressure in patients with ductus arteriosus under different hemodynamic states. Circulation 76:1081–1091PubMedCrossRef
8.
Zurück zum Zitat Torres AJ, Srivastava S, Parness IA, Bridges ND (2003) Echocardiographic predictors of failure in patients undergoing coil occlusion of patent ductus arteriosus. J Am Soc Echocardiogr 16:1063–1067PubMedCrossRef Torres AJ, Srivastava S, Parness IA, Bridges ND (2003) Echocardiographic predictors of failure in patients undergoing coil occlusion of patent ductus arteriosus. J Am Soc Echocardiogr 16:1063–1067PubMedCrossRef
9.
Zurück zum Zitat Tynan M, Huggon I, Rosenthal E et al (1999) Coil occlusion of the arterial duct. J Interv Cardiol 12:73–77CrossRef Tynan M, Huggon I, Rosenthal E et al (1999) Coil occlusion of the arterial duct. J Interv Cardiol 12:73–77CrossRef
Metadaten
Titel
Usefulness of Doppler Derived End Diastolic Flow Gradient Across the Patent Ductus Arteriosus in Selecting Coils for Ductal Occlusion
verfasst von
Amit Kumar Chaurasia
S. Harikrishnan
S. Bijulal
K. M. Krishnamoorthy
S. Sivasankaran
J. A. Tharakan
Publikationsdatum
01.02.2012
Verlag
Springer-Verlag
Erschienen in
Pediatric Cardiology / Ausgabe 2/2012
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-011-0118-2

Weitere Artikel der Ausgabe 2/2012

Pediatric Cardiology 2/2012 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.